Where Can I Get a HOMA-IR Test for Insulin Resistance?

Any lab that can measure fasting blood glucose and fasting insulin can generate the numbers you need for a HOMA-IR score. That means most commercial labs, hospital laboratories, and many primary-care offices with in-house blood work can get you there. The catch is that HOMA-IR is not always offered as a standalone named test on a lab menu, and your doctor may need to order fasting glucose and fasting insulin separately, then calculate the score from the results. How you prepare for the blood draw, which lab processes your sample, and how your results are interpreted all matter more than most people realize.

What You Are Actually Ordering

HOMA-IR stands for Homeostasis Model Assessment of Insulin Resistance. It is not a separate lab procedure or a special piece of equipment. It is a calculation that uses two routine blood values: your fasting plasma glucose and your fasting plasma insulin. The formula multiplies those two numbers together and divides by a constant (22.5, when glucose is measured in mmol/L and insulin in µU/mL).¹ Some labs report HOMA-IR automatically when both values are ordered together; others simply hand you the raw glucose and insulin numbers and leave the arithmetic to your clinician.

Because the test relies on a standard fasting blood draw, you do not need to visit a specialized endocrinology center. Large commercial lab networks in the United States, such as Quest Diagnostics and Labcorp, offer fasting insulin panels that your primary-care physician can order. Walk-in lab services that let you order blood work without a doctor’s referral also carry fasting insulin and glucose panels. Outside the US, similar commercial and hospital laboratories perform the same tests. The real question is usually not “where” but “will my doctor order it,” since some clinicians still default to fasting glucose or HbA1c alone for screening and may not think to add fasting insulin unless you ask.

How to Prepare for the Blood Draw

Getting a reliable HOMA-IR score hinges on the quality of your fasting state. European laboratory-medicine guidelines recommend fasting for 12 hours before the draw, during which you can drink water but should avoid food, alcohol (for at least 24 hours beforehand), caffeine, and cigarettes on the morning of the test. Blood is best drawn between about 7 and 9 a.m.² The morning timing is not arbitrary: insulin and glucose follow circadian patterns, and drawing later in the day can shift both values in ways that muddy the calculation.

A common mistake is assuming that skipping breakfast on the morning of a late-afternoon appointment counts as fasting. If you ate dinner at 8 p.m. and show up for a 2 p.m. draw, you have technically fasted for 18 hours, but your cortisol-driven glucose rhythm is in a different place than it would be at 8 a.m. For the most consistent comparison over time, stick to a morning draw after an overnight fast.

Why the Lab You Choose Matters

Here is where things get less straightforward. Glucose assays are well standardized across laboratories, but insulin assays are not. A large inter-laboratory study found that the same blood sample could produce HOMA-IR values that varied by about 25% from one lab to another, driven almost entirely by differences in how each lab’s insulin assay reads. A HOMA-IR of 2.0 at one facility corresponded to values ranging from 1.3 to 2.1 at six other labs.³ That spread is wide enough to push someone across a diagnostic threshold depending on which lab processed the sample.

The practical takeaway: if you plan to track your HOMA-IR over time, use the same lab and ideally the same assay platform for every draw. Comparing a result from one lab chain to a result from a hospital lab six months later is not an apples-to-apples comparison. If your doctor switches labs, mention it so the trend is interpreted cautiously.

How Samples Should Be Handled

Insulin is a fragile molecule once it leaves your body. How the blood tube is processed after the draw can meaningfully affect your result. Research on pre-analytical sample handling shows that insulin levels in plain serum tubes left unspun at room temperature can drop to roughly 62% of their true value, while insulin in plasma tubes with an anticoagulant additive stays above 90% of baseline for up to 24 hours.⁴ A separate study confirmed the pattern: insulin stored unspun at room temperature in serum lost about 80% of its concentration over 72 hours, compared to a loss of around 23% in plasma under the same conditions.⁵

You cannot control what happens to your tube after the phlebotomist labels it, but you can influence the situation. Drawing blood at a high-volume lab where samples are spun and processed quickly is better than drawing at a small satellite office where tubes might sit in a rack for hours before being shipped. If you are given a choice of collection site, pick one attached to or very near the processing facility.

What Your Number Means (and Why Cutoffs Are Slippery)

Once you have a HOMA-IR value in hand, interpreting it is surprisingly complicated. There is no single universally agreed-upon cutoff that separates “insulin resistant” from “insulin sensitive.” Published thresholds for identifying insulin resistance range from about 1.4 to nearly 4.0, depending on the population studied, the statistical method used to define the cutoff, and the clinical endpoint researchers were trying to predict.⁶

Ethnicity plays a large role. Studies in Japanese populations have suggested cutoffs around 1.7 to 2.4, while Western populations often use values closer to 2.5 or higher.⁷ A study in a Chinese population under 45 confirmed that different ethnic backgrounds, health conditions, and even the statistical technique chosen to set the threshold all shift the number.⁸ So when a wellness influencer or online calculator tells you “above 2.5 means insulin resistant,” that threshold may not be calibrated for your background, your body composition, or the specific condition your doctor is trying to rule in or out.

A more clinically grounded approach from a study that compared HOMA-IR against the gold-standard clamp technique found that a HOMA-IR above about 5.9 picked up insulin resistance with good sensitivity (roughly 89%) and moderate specificity, while values between about 2.8 and 5.9 required additional information like HDL cholesterol to classify someone accurately.⁹ That study used a predominantly American population and a rigorous comparison method, but the point stands: HOMA-IR is best treated as a spectrum, not a binary switch.

How Reliable Is HOMA-IR Compared to the Gold Standard

The gold-standard measurement of insulin resistance is the hyperinsulinemic-euglycemic clamp, a research procedure where insulin is infused intravenously while glucose is dripped in at whatever rate keeps blood sugar steady. The amount of glucose needed tells researchers how sensitive your cells are to insulin. It takes hours, requires an IV setup, and is essentially never done outside of a research ward. HOMA-IR exists precisely because the clamp is impractical for routine clinical use.

HOMA-IR correlates with clamp results, but the agreement is not perfect. One Korean study that directly compared the two methods found a statistically significant inverse correlation between HOMA-IR and clamp-measured glucose disposal, but only moderate agreement when it came to actually categorizing individuals as insulin resistant or not.¹⁰ In plain terms, HOMA-IR reliably tracks the direction of your insulin resistance (higher values do mean more resistance) but can misjudge where you fall relative to a clinical threshold in borderline cases. For most people, that level of precision is plenty. For someone whose clinical management hinges on a precise cutoff, additional testing or clinical context helps.

The Updated HOMA2 Calculator

The original HOMA formula published in the 1980s uses a simple linear equation. An updated version, called HOMA2, was released in 1998 as a computer-based model that accounts for variations in how the liver and pancreas actually interact, and it was recalibrated so that normal beta-cell function and insulin sensitivity both equal 100% in healthy young adults.¹¹ The HOMA2 calculator is freely available online from the University of Oxford’s Diabetes Trials Unit. You enter your fasting glucose and fasting insulin (or C-peptide, if that was measured instead), and it returns HOMA2-IR along with a beta-cell function estimate.

If your lab only reports the original HOMA-IR formula, you can still run your numbers through the HOMA2 calculator yourself. The two versions usually trend in the same direction, but HOMA2 handles extreme values of glucose and insulin more accurately. Neither version is “wrong,” but knowing which one your provider used prevents confusion if you are comparing results over time or between clinicians.

Alternatives That Skip the Insulin Assay

Because fasting insulin assays are unstandardized and add cost, researchers have explored surrogate markers that estimate insulin resistance from cheaper, more widely available lab values. The triglyceride-glucose (TyG) index, calculated from fasting triglycerides and fasting glucose, has gained attention as a practical alternative. A study comparing the two markers found that the TyG index had slightly better accuracy for identifying metabolic syndrome, with sensitivity around 68% and specificity around 94%, compared with about 64% sensitivity and 89% specificity for HOMA-IR.¹² A separate study in a Yemeni population showed a similar edge for the TyG index in predicting type 2 diabetes.¹³

The TyG index is worth knowing about because most basic metabolic and lipid panels already include fasting triglycerides and glucose, meaning you may already have the data sitting in your chart. If cost or access to a fasting insulin assay is a barrier, ask your doctor whether a TyG calculation could serve as a rough proxy. It is not identical to HOMA-IR, and it reflects a somewhat different slice of metabolic health (triglyceride metabolism plays a bigger role), but for screening purposes the two track closely enough to be useful.

Another index you may encounter is QUICKI (Quantitative Insulin Sensitivity Check Index), which uses the same fasting glucose and insulin values as HOMA-IR but applies a logarithmic transformation. Head-to-head comparisons show that QUICKI and HOMA-IR have essentially identical diagnostic accuracy.¹⁴ The two are mathematically related, so picking one over the other is more about which your provider’s software defaults to than about any real clinical advantage.

HOMA-B and Beta-Cell Function

When your lab runs fasting glucose and insulin, the same pair of numbers can also feed a companion calculation called HOMA-B (or HOMA-%B), which estimates how well your pancreatic beta cells are producing insulin.¹⁵ While HOMA-IR tells you how resistant your tissues are to insulin’s signal, HOMA-B tells you how hard your pancreas is working to compensate. Declining beta-cell function is often the step that tips someone from insulin resistance into actual diabetes, because the pancreas can no longer keep up with demand.

Research suggests that drops in beta-cell function can show up even while fasting glucose is still normal, making HOMA-B a potentially earlier warning signal than glucose alone.¹⁶ If you are going to the trouble of getting fasting glucose and insulin measured, it costs nothing extra to ask your clinician for a HOMA-B calculation as well. Together, HOMA-IR and HOMA-B paint a more complete metabolic picture than either number alone. One study examining how well each score predicted progression to diabetes and prediabetes subtypes found that HOMA-IR was the stronger predictor for most outcomes, but HOMA-B added useful information about which prediabetic pathway a person was on.¹⁷

Using HOMA-IR to Track Lifestyle Changes

One of the most practical reasons to get a HOMA-IR test is to have a baseline before starting a diet, exercise program, or medication, and then to remeasure after a few months to see whether it moved. Unlike HbA1c, which reflects average blood sugar over two to three months and may not budge much in people who are insulin resistant but not yet diabetic, HOMA-IR can shift relatively quickly with changes in body composition and physical activity.

A study of obese adults who completed a 12-week intensive lifestyle program that included high-intensity interval training found that average HOMA-IR dropped from about 3.6 to 2.8, a meaningful improvement, even though HbA1c barely changed.¹⁸ A separate study in obese children showed significant reductions in both insulin and HOMA-IR after a 16-week exercise program, again without major changes in fasting glucose.¹⁹ The pattern makes sense: exercise and weight loss improve how cells respond to insulin, and HOMA-IR captures that improvement earlier than glucose-based markers do.

If you are using HOMA-IR to monitor your own progress, the same caveats about lab consistency and fasting protocol apply doubly. A drop from 3.6 to 2.8 is only interpretable if both draws were done under the same conditions. Get your blood taken at the same lab, at roughly the same time of morning, after the same fasting window. That way the only variable that changed is you.

When HOMA-IR Can Mislead

HOMA-IR works best as a population-level screening tool and a personal trend tracker. It can mislead in a few specific situations. People who are already on insulin therapy or insulin secretagogues will have artificially altered fasting insulin levels, making the calculation unreliable. People with very low beta-cell function (for instance, those with late-stage type 2 diabetes or type 1 diabetes) may have low fasting insulin not because they are insulin sensitive but because their pancreas is failing, which pushes HOMA-IR deceptively low.

Acute illness, sleep deprivation, and stress hormones can all temporarily spike fasting glucose or insulin, producing a one-off HOMA-IR that overestimates your usual level of resistance. A single elevated result in someone who was sick or sleep-deprived the night before is not diagnostic. Repeat the draw under better conditions before drawing conclusions.

Polycystic ovary syndrome (PCOS) is another context where HOMA-IR shows up frequently. Many clinicians use it to evaluate insulin resistance in PCOS patients, but the same cutoff ambiguity applies: there is no PCOS-specific threshold validated across populations, and the test should be interpreted alongside clinical symptoms and other lab work rather than in isolation.

How to Ask Your Doctor

If your provider is unfamiliar with ordering HOMA-IR specifically, the request is simple: a fasting insulin level and a fasting glucose level drawn from the same blood sample. Some electronic medical record systems will auto-calculate HOMA-IR once both values are in the chart; others will not. You or your provider can plug the numbers into the Oxford HOMA2 calculator or use the original formula by hand. Insurance coverage varies: fasting glucose is almost universally covered, but fasting insulin may not be covered as a screening test in the absence of a diabetes-related diagnosis code. If cost is a concern, direct-to-consumer lab services often sell fasting insulin panels for a flat fee without requiring insurance, typically in the range of $30 to $60 for the insulin assay alone.

For people outside the traditional healthcare system who want to track metabolic health proactively, several telehealth and wellness-lab companies now bundle fasting glucose and insulin into “metabolic health” or “insulin resistance” panels. These are legitimate lab tests processed by accredited laboratories; the difference is in the ordering pathway, not the quality of the assay. Just verify that the lab uses a well-characterized insulin immunoassay and processes serum or plasma samples promptly, since sample handling affects results as described earlier.